CAPITAL MANAGEMENT CORP /VA - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 291 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.77 and the average weighting 0.1%.

Quarter-by-quarter ownership
CAPITAL MANAGEMENT CORP /VA ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$3,517,000
-33.7%
195,489
-12.5%
1.29%
-4.7%
Q4 2019$5,301,000
-16.9%
223,490
-3.7%
1.35%
-22.6%
Q3 2019$6,376,000
+1.3%
232,030
+21.9%
1.75%
+0.3%
Q2 2019$6,297,000
+4.6%
190,290
+10.7%
1.74%
+5.2%
Q1 2019$6,022,000
-33.9%
171,870
-37.4%
1.65%
-41.5%
Q4 2018$9,117,000
-19.6%
274,457
+21.9%
2.83%
-2.3%
Q3 2018$11,340,000
+76.9%
225,232
+110.3%
2.90%
+68.0%
Q2 2018$6,409,000
+0.3%
107,080
-23.3%
1.72%
+0.2%
Q1 2018$6,391,000
+18.9%
139,535
+3.5%
1.72%
+18.0%
Q4 2017$5,373,000
+20.4%
134,820
+20.8%
1.46%
+14.4%
Q3 2017$4,464,000
-11.5%
111,600
-4.6%
1.28%
-15.3%
Q2 2017$5,043,000
+32.4%
117,000
-3.8%
1.50%
+27.5%
Q1 2017$3,808,000
+24.2%
121,660
+0.2%
1.18%
+15.3%
Q4 2016$3,066,000
+94.3%
121,440
+90.4%
1.02%
+75.5%
Q3 2016$1,578,000
+117.4%
63,795
+79.0%
0.58%
+107.5%
Q2 2016$726,00035,6300.28%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders